(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 3. Rspo3 acts via Wnt/β-catenin signaling to induce
Vegf. (A-C) RT-PCR analysis or quantitative PCR analysis
(qPCR) of indicated marker genes in ventral marginal zones (VMZ). Four-cell
stage Xenopus embryos were injected with 2.5 ng of Control Mo or
Rspo3 Mo, 10 ng of VEGF Mo, 50 pg Xenopus Rspo2 mRNA, 250 pg
dominant-negative Wnt8 (dnWnt8), 50 pg pCSKA-Wnt8 DNA, 150
pg Xenopus Dkk1 DNA, 50 pg Xenopus Rspo3 mRNA or 250 pg
Xenopus VEGF-A170 mRNA, as indicated, into each ventral
blastomere. VMZs were explanted at stage 10.5, cultured until stage 28 with or
without treatment of VEGF receptor inhibitors (KRN or MAZ), and processed for
RT-PCR (A,B) or qPCR (C). -RT, minus reverse transcription control. (D)
Four-cell stage embryos were injected with 2.5 ng of Control Mo or Rspo3 Mo,
as indicated, into both ventral blastomeres. Embryos were cultured until the
indicated stage and prospective vbi regions were dissected for qPCR analysis.
Gene expression in uninjected vbi explants was set to 100% (control).